Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Queensland Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076570

« Back to Dashboard

NDA 076570 describes TRIMETHOBENZAMIDE HYDROCHLORIDE, which is a drug marketed by Gavis Pharms, Sun Pharm Industries, Hospira, Luitpold, Smith And Nephew, Solopak, and Watson Labs, and is included in ten NDAs. It is available from eight suppliers. Additional details are available on the TRIMETHOBENZAMIDE HYDROCHLORIDE profile page.

The generic ingredient in TRIMETHOBENZAMIDE HYDROCHLORIDE is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.

Summary for 076570

Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 076570

Physiological EffectEmesis Suppression

Suppliers and Packaging for NDA: 076570

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076570 ANDA Rebel Distributors Corp. 21695-448 21695-448-10 10 CAPSULE in 1 BOTTLE, PLASTIC (21695-448-10)
TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076570 ANDA Lake Erie Medical DBA Quality Care Products LLC 35356-473 35356-473-00 10 CAPSULE in 1 BOTTLE, PLASTIC (35356-473-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Aug 28, 2003TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Cantor Fitzgerald
Fish and Richardson
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: